Search clinical trials for: placebo of cilostazol

Total 182051 results

Kobe City General Hospital
Osaka University; Okayama University; Kobe University; Nagoya University; Kyoto University and other collaborators

Completed

Carotid Artery Stenting With Cilostazol Addition for Restenosis (CAS-CARE)

In-stent Restenosis After Carotid Artery Stenting

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction. (CSPS)

Cerebral Infarction

Japan
Noorik Biopharmaceuticals AG

Terminated

A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19

Covid19 | Hypoxemia

Spain, Croatia
Beijing Tiantan Hospital
NeuroDawn Pharmaceutical Co., Ltd.

Not yet recruiting

EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE)

Acute Ischemic Stroke | Large Vessel Occlusion | Reperfusion
CardioVascular Research Foundation, Korea
Otsuka Korea

Completed

Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent (DECLARELONG)

Coronary Artery Disease

Korea, Republic of
Korea University Anam Hospital

Unknown

Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness

Diabetes Mellitus, Type 2 | Metabolic Syndrome X

Korea, Republic of
Jong Woo Chung
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

A Study on the Effect of Cilostazol in Patients With Chronic Tinnitus (CITI-ESR)

Tinnitus

Korea, Republic of
Asan Medical Center
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Overcome Biochemical Aspirin Resistance Through Cilostazol Combination (ARCC)

Cerebral Infarction

Korea, Republic of
Mutual Pharmaceutical Company, Inc.

Completed

Fasted Bioavailability Study of Cilostazol Tablets, 100 mg

Therapeutic Equivalency
Mutual Pharmaceutical Company, Inc.

Completed

Fasted Bioavailability Study of Cilostazol Tablets, 50mg

Therapeutic Equivalency, Healthy
Sadat City University

Active, not recruiting

Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease

Fatty Liver, Nonalcoholic

Egypt
University of Minnesota

Completed

Cilostazol for HFpEF

Heart Failure With Preserved Ejection Fraction

United States
Ascension South East Michigan

Recruiting

Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)

Aneurysmal Subarachnoid Hemorrhage

United States
JIMRO Co., Ltd.

Active, not recruiting

Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions

Coronary Artery Disease

Japan
Kowa Research Institute, Inc.

Completed

Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication

Intermittent Claudication

United States, Russian Federation
University of Edinburgh
University of Nottingham; British Heart Foundation

Completed

LACunar Intervention (LACI-2) Trial-2 (LACI-2)

Cerebral Small Vessel Diseases | Stroke, Lacunar

United Kingdom
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

Pain
Sadat City University

Active, not recruiting

The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis

Osteoarthritis

Egypt
SK Chemicals Co., Ltd.

Completed

Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo

Healthy

Korea, Republic of
Yonsei University
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Synergistic Effect of Combination Therapy With Cilostazol and Probucol on Plaque Stabilization and Lesion Regression: Serial Intravascular Ultrasound and Virtual Histology Study(SECURE Study)

Therapy

Korea, Republic of
Gyeongsang National University Hospital
Korea Otsuka Pharmaceutical Co., Ltd.

Unknown

Cilostazol and Endothelial Progenitor Cell (EPISODE)

Myocardial Infarction, Acute
Jong Woo Chung
Asan Medical Center; SK Chemicals Co., Ltd.

Terminated

Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy (REREV)

Recurrent Vestibulopathy

Korea, Republic of
Otsuka Beijing Research Institute

Completed

Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject

Atherosclerosis Cerebral Infarction

China
Otsuka Pharmaceutical, Inc., Philippines

Completed

Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines (ASCEND)

Polyneuropathy

Philippines
Kansai Rosai Hospital
Association for Establishment of Ebvidence in Interventions

Unknown

Sufficient Treatment of Peripheral Intervention by Cilostazol (STOP-IC)

Arteriosclerosis Obliterans

Japan
Asan Medical Center
Korea Otsuka Pharmaceutical Co., Ltd.

Unknown

PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study (PICASSO-IMT)

Brain Ischemia | Intracranial Hemorrhages
Genovate Biotechnology Co., Ltd.,

Terminated

Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

Intermittent Claudication

United States
Genovate Biotechnology Co., Ltd.,

Completed

Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

Intermittent Claudication

United States
Translational Research Center for Medical Innovation...
China National Center for Cardiovascular Diseases; Kyushu University; Tohoku... and other collaborators

Completed

Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis

Cerebrovascular Disease

Japan
Teva Pharmaceuticals USA

Completed

Cilostazol 50 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cilostazol 100 mg Tablet Formulations Under Fasting Conditions

Healthy

United States
Danish Headache Center

Completed

The Effect of Sumatriptan and Placebo Injection on Cilostazol Induced Headache

Migraine

Denmark
Sanofi

Completed

Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease (ACCELA)

Intermittent Claudication

United States, France, Canada, Poland, Russian Federation, Austria, South Africa
Genovate Biotechnology Co., Ltd.,

Completed

BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

Intermittent Claudication

United States
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety

Peripheral Artery Disease

Korea, Republic of
Genovate Biotechnology Co., Ltd.,

Completed

Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

Intermittent Claudication

United States
Sadat City University

Completed

The Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Major Depressive Disorder.

Major Depressive Disorder

Egypt
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mg

Healthy

United States
Genovate Biotechnology Co., Ltd.,

Completed

BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers

Intermittent Claudication

United States
Colorado Prevention Center
Otsuka Pharmaceutical Co., Ltd.

Completed

Evaluation of Cilostazol in Combination With L-Carnitine (ECLECTIC)

Peripheral Arterial Disease | Intermittent Claudication | Peripheral Vascular Disease

United States
Bausch & Lomb Incorporated

Completed

Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge

Allergic Conjunctivitis

United States
Samsung Medical Center
Inje University

Completed

Effect of Cilostazol on the Pharmacokinetics of Simvastatin

Healthy

Korea, Republic of
Seoul National University Hospital

Completed

The Efficacy of CILostazol ON Ischemic Complications After DES Implantation (CILON-T)

Coronary Artery Disease

Korea, Republic of
National Cheng-Kung University Hospital
Department of Health, Executive Yuan, R.O.C. (Taiwan)

Unknown

Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery Disease

Coronary Artery Disease

Taiwan
Yonsei University

Completed

Changes of Inflammatory Cytokines in the Tears of Moderate and Severe MGD Treated With Topical Loteprednol Etabonate

Moderate and Severe Meibomiang Gland Dysfunction (Stage 3 or Stage 4 Meibomiang Gland Dysfunction)

Korea, Republic of
Otsuka Beijing Research Institute

Completed

A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy

Diabetic Nephropathy

China
National Cheng-Kung University Hospital
Department of Health, Executive Yuan, R.O.C. (Taiwan)

Completed

Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in High Risk for Cardiovascular Disease

Cardiovascular Diseases

Taiwan
Yonsei University

Unknown

Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study)

Critical Limb Ischemia

Korea, Republic of
National Cheng-Kung University Hospital
Department of Health, Executive Yuan, R.O.C. (Taiwan)

Completed

Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD)

Peripheral Arterial Diseases

Taiwan
Kyunghee University Medical Center

Completed

Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease (CKD)

Chronic Kidney Disease | Stable Angina

Korea, Republic of

Search clinical trials for: placebo of cilostazol

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations